{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:30:43Z","timestamp":1768685443269,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004730.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000}}],"reference-count":71,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004730.pub5","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T18:09:46Z","timestamp":1603130986000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Drug treatments for managing cystic fibrosis-related diabetes"],"prefix":"10.1002","volume":"2020","author":[{"given":"Gary M","family":"Onady","sequence":"additional","affiliation":[{"name":"Boonshoft School of Medicine; Wright State University; Dayton Ohio USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne","family":"Stolfi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Children's Medical Center; Dayton Ohio USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"10.1002\/14651858.CD004730.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2431-14-70","article-title":"Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus","volume":"14","author":"Ballmann","year":"2014","journal-title":"BMC Pediatrics"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0002|cit2","first-page":"421","article-title":"Repaglinide versus insulin in the treatment of CFRD diagnosed by screening: an open prospective randomized study","volume":"48 Suppl 26","author":"Ballmann","year":"2013","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S1569-1993(13)60095-8","article-title":"Treatment of early diagnosed CFRD with oral drugs verus insulin: An open prospective randomized study","volume":"12 Suppl 1","author":"Ballmann","year":"2013","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD004730.pub5-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S2213-8587(17)30400-X","article-title":"Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial","volume":"6","author":"Ballmann","year":"2018","journal-title":"The Lancet Diabetes and Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD004730.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2013.06.001","article-title":"Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test","volume":"13","author":"Schmid","year":"2014","journal-title":"Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society"},{"issue":"2","key":"10.1002\/14651858.CD004730.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jcf.2007.07.004","article-title":"Glargine versus NPH insulin in cystic fibrosis related diabetes","volume":"7","author":"Grover","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0007|cit7","first-page":"335","article-title":"Insulin and glucose excursion following pre-meal insulin lispro or repaglinide in CFRD","volume":"32 (Suppl 22)","author":"Milla","year":"2001","journal-title":"Pediatric Pulmonology"},{"issue":"10","key":"10.1002\/14651858.CD004730.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/diacare.24.10.1706","article-title":"Insulin and glucose excursion following pre-meal insulin lispro or repaglinide in cystic fibrosis-related diabetes","volume":"24","author":"Moran","year":"2001","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1002\/14651858.CD004730.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD004730.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1249\/MSS.0000000000001104","article-title":"Combined exercise training improves glycemic control in adult with cystic fibrosis","volume":"49","author":"Beaudoin","year":"2017","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"2","key":"10.1002\/14651858.CD004730.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1249\/MSS.0000000000001104","article-title":"Combined exercise training improves glycemic control in adult with cystic fibrosis","volume":"49","author":"Beaudoin","year":"2017","journal-title":"Medicine and Science in Sports and Exercise"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0012|cit12","first-page":"367","article-title":"Effects of a partially supervised combined exercise program on glycemic control in cystic fibrosis: pilot study","volume":"50 Suppl 41","author":"Beaudoin","year":"2015","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0013|cit13","first-page":"348","article-title":"A dose-ranging study of efficacy of TheraCLEC-Total for treatment of pancreatic insufficiency","volume":"40 (Suppl 28)","author":"Borowitz","year":"2005","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0014|cit14","first-page":"142","article-title":"A phase 2 study of TheraCLEC-Total enzymes in CF patients with pancreatic insufficiency (PI)","volume":"40 (Suppl 28)","author":"Borowitz","year":"2005","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0015|cit15","first-page":"S56","article-title":"Treatment with ALTU-135 results in a positive inverse relationship between coefficient of fat absorption with stool weight in subjects with cystic fibrosis-related pancreatic insufficiency","volume":"5 Suppl","author":"Borowitz","year":"2006","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0016|cit16","first-page":"S56","article-title":"Enhanced coefficient of fat absorption using a novel pancreatic enzyme preparation, ALTU-135, with concomitant use of a proton pump inhibitor","volume":"5 Suppl","author":"Borowitz","year":"2006","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0017|cit17","first-page":"386","article-title":"Changes in coefficients of fat and nitrogen absorption in subjects with cystic fibrosis, pancreatic insufficiency, and cystic fibrosis-related diabetes mellitus receiving a novel pancreatic enzyme product, ALTU-135","volume":"41 Suppl 29","author":"Murray","year":"2006","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD004730.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archpedi.156.6.533","article-title":"A randomized, controlled trial of a community-based support program for families of children with chronic illness: pediatric outcomes","volume":"156","author":"Chernoff","year":"2002","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004730.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archpedi.155.7.771","article-title":"Maternal outcomes of a randomized controlled trial of a community-based support program for families of children with chronic illnesses","volume":"155","author":"Ireys","year":"2001","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"8","key":"10.1002\/14651858.CD004730.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/jpepsy\/jsp138","article-title":"Risk factors associated with depressive symptoms in caregivers of children with type 1 diabetes or cystic fibrosis","volume":"35","author":"Driscoll","year":"2010","journal-title":"Journal of Pediatric Psychology"},{"issue":"10","key":"10.1002\/14651858.CD004730.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.2337\/dc11-0388","article-title":"Does blood glucose monitoring increase prior to clinic visits in children with type 1 diabetes?","volume":"34","author":"Driscoll","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD004730.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cct.2009.01.008","article-title":"Predictors of study completion and withdrawal in a randomized clinical trial of a pediatric diabetes adherence intervention","volume":"30","author":"Driscoll","year":"2009","journal-title":"Contemporary Clinical Trials"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD004730.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"A484","DOI":"10.2337\/db18-1820-P","article-title":"Effects of GLP-1 and GIP on insulin secretion in glucose intolerant, pancreatic insufficient cystic fibrosis","volume":"67","author":"Eiel","year":"2018","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0024|cit24","first-page":"222","article-title":"Effect of GLP-1 and GIP on insulin secretion in glucose intolerant, pancreatic insufficient cystic fibrosis","volume":"54 Suppl 2","author":"Kelly","year":"2019","journal-title":"Pediatric Pulmonology"},{"issue":"7","key":"10.1002\/14651858.CD004730.pub5-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/pedi.12700","article-title":"\u03b2-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose \u2265155\u2009mg\/dL","volume":"19","author":"Nyirjesy","year":"2018","journal-title":"Pediatric Diabetes"},{"issue":"9","key":"10.1002\/14651858.CD004730.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2337\/diacare.28.9.2333","article-title":"Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes?","volume":"28","author":"Franzese","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/dom.13544","article-title":"Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: a randomized crossover trial","volume":"21","author":"Geyer","year":"2019","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD004730.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcf.2008.12.001","article-title":"Use of the insulin pump in treat cystic fibrosis related diabetes","volume":"8","author":"Hardin","year":"2009","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD004730.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ppul.20263","article-title":"Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis","volume":"40","author":"K\u00f6nig","year":"2005","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"10.1002\/14651858.CD004730.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ajcn.81.2.421","article-title":"Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis","volume":"81","author":"Mahroukh","year":"2005","journal-title":"American Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD004730.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","article-title":"Epidemiology of cystic fibrosis-related diabetes","volume":"146","author":"Marshall","year":"2005","journal-title":"Journal of Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD004730.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2337\/diacare.28.9.2141","article-title":"Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis","volume":"28","author":"Milla","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S1569-1993(09)60322-2","article-title":"Efficacy of slow release insulin in patients with cystic fibrosis and glucide intolerance","volume":"8 (Suppl 2)","author":"Minicucci","year":"2009","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD004730.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1399-5448.2011.00810.x","article-title":"Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial","volume":"13","author":"Minicucci","year":"2012","journal-title":"Pediatric Diabetes"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004730.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1569-1993(08)60493-2","article-title":"New diagnostic and therapeutic approaches in cystic fibrosis related diabetes (CFRD)","volume":"7","author":"Minicucci","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0036|cit36","unstructured":"Cystic Fibrosis (CF) Exacerbation and Insulin Treatment clinicaltrials.gov\/show\/nct01149005"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0037|cit37","unstructured":"The impact of insulin therapy on protein turnover in pre-diabetic cystic fibrosis patients clinicaltrials.gov\/ct2\/show\/NCT02496780"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6823-6-4","article-title":"Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study","volume":"6","author":"Onady","year":"2006","journal-title":"BMC Endocrine Disorders"},{"issue":"2","key":"10.1002\/14651858.CD004730.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000023128","article-title":"Evaluation of glucose tolerance and insulin secretion in cystic fibrosis patients","volume":"49","author":"Peraldo","year":"1998","journal-title":"Hormone Research"},{"issue":"1","key":"10.1002\/14651858.CD004730.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcf.2005.09.002","article-title":"Use of continuous subcutaneous insulin infusion in cystic fibrosis patients with cystic fibrosis-related diabetes awaiting transplantation","volume":"5","author":"Reali","year":"2006","journal-title":"Journal of Cystic Fibrosis"},{"issue":"3","key":"10.1002\/14651858.CD004730.pub5-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jcf.2010.02.001","article-title":"Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation","volume":"9","author":"Sc","year":"2010","journal-title":"Journal of Cystic Fibrosis"},{"issue":"3","key":"10.1002\/14651858.CD004730.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcf.2006.07.005","article-title":"Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: Three case reports","volume":"6","author":"Sulli","year":"2007","journal-title":"Journal of Cystic Fibrosis"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD004730.pub5-BIB0043|cit43","first-page":"P3773","article-title":"One-year pulmonary safety and efficacy of inhaled insulin as adjunctive therapy in type 2 diabetes patients poorly controlled on oral agent monotherapy","volume":"24","author":"Teeter","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD004730.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/ajcn\/69.5.913","article-title":"Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus","volume":"69","author":"Ward","year":"1999","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S1569-1993(14)60040-0","article-title":"A placebo-controlled trial of insulin therapy with or without adjuvant metformin in patients with cystic fibrosis-related diabetes (CFRD)","volume":"13 Suppl 2","author":"Lind van Wijngaarden-van den Berg","year":"2014","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0046|cit46","unstructured":"Beta-cell Response to Incretin Hormones in Cystic Fibrosis clinicaltrials.gov\/show\/nct01851694"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0047|cit47","unstructured":"Redox Imbalance and the Development of Cystic Fibrosis Diabetes clinicaltrials.gov\/show\/nct02202876"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/diacare.27.2007.S15","article-title":"Standards of medical care in diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0049|cit49","first-page":"398","article-title":"Treatment of CFRD diagnosed by annual OGT screening: real life data from a longitudinal registry study from Germany","volume":"53 Supplement 2","author":"Wosnick","year":"2018","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD004730.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00005176-199404000-00021","article-title":"Glipizide treatment of patients with cystic fibrosis and impaired glucose tolerance","volume":"18","author":"Culler","year":"1994","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD004730.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004730.pub5-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s13300-017-0273-4","article-title":"Pioglitazone and the risk of bladder cancer: a meta-analysis","volume":"8","author":"Filipova","year":"2017","journal-title":"Diabetes Therapy"},{"issue":"3","key":"10.1002\/14651858.CD004730.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-3476(88)80315-9","article-title":"Diabetes mellitus associated with cystic fibrosis","volume":"112","author":"Finkelstein","year":"1988","journal-title":"Journal of Pediatrics"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD004730.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0022-3476(97)70015-5","article-title":"Effects of growth hormone treatment in children with cystic fibrosis: the National Cooperative Growth Study experience","volume":"131","author":"Hardin","year":"1997","journal-title":"Journal of Pediatrics"},{"issue":"7414","key":"10.1002\/14651858.CD004730.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0056|cit56","unstructured":"Higgins JP Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0057|cit57","first-page":"306","article-title":"Diabetic retinopathy in patients with cystic fibrosis related diabetes (CFRD)","volume":"24 (Suppl 14)","author":"Landers","year":"1997","journal-title":"Pediatric Pulmonology"},{"issue":"8","key":"10.1002\/14651858.CD004730.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1651-2227.1994.tb13156.x","article-title":"Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections","volume":"83","author":"Lanng","year":"1994","journal-title":"Acta Paediatrica"},{"issue":"S48","key":"10.1002\/14651858.CD004730.pub5-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1002\/ppul.23762","article-title":"CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis","volume":"52","author":"Moheet","year":"2017","journal-title":"Pediatric Pulmonology"},{"issue":"5","key":"10.1002\/14651858.CD004730.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-3476(05)80032-0","article-title":"Pancreatic endocrine function in cystic fibrosis","volume":"118","author":"Moran","year":"1991","journal-title":"Journal of Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD004730.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD004730.pub5-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.rpped.2015.12.010","article-title":"Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review","volume":"34","author":"Pu","year":"2016","journal-title":"Revista Paulistade Pediatria"},{"issue":"6","key":"10.1002\/14651858.CD004730.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.08-1190","article-title":"Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest"},{"issue":"5","key":"10.1002\/14651858.CD004730.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ppul.1143","article-title":"Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents","volume":"32","author":"Rosenecker","year":"2001","journal-title":"Pediatric Pulmonlogy"},{"issue":"1","key":"10.1002\/14651858.CD004730.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2013.06.001","article-title":"Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test","volume":"13","author":"Schmid","year":"2014","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0066|cit66","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P et al on behalf of the Cochrane Applicability and Recommendations Methods Group and the Cochrane Statistical Methods Group Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, (editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD004730.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/dc06-1576","article-title":"Microvascular complications in cystic fibrosis-related diabetes","volume":"30","author":"Schwarzenberg","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD004730.pub5-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dme.13959","article-title":"Cystic fibrosis and insulin therapy: a reality check","volume":"00","author":"Warren","year":"2019","journal-title":"Diabetic Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004730.pub5-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004730.pub2","article-title":"Insulin and oral agents for managing cystic fibrosis-related diabetes","author":"Onady","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD004730.pub5-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004730.pub3","article-title":"Insulin and oral agents for managing cystic fibrosis-related diabetes","author":"Onady","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004730.pub5-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004730.pub4","article-title":"Insulin and oral agents for managing cystic fibrosis-related diabetes","author":"Onady","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T19:55:42Z","timestamp":1623354942000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004730.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":71,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004730.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]}}}